On November 16, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that its President and Chief Executive Officer, Rodney Varner, will be presenting in November with CEO Roadshow to provide a company overview of its novel gene therapies in cancer and diabetes to investors (Press release, Genprex, NOV 16, 2021, View Source [SID1234595689]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the November CEO Roadshow webinar:

Host: CEO Roadshow

Date and Time: Wednesday, Nov. 17 at 11 a.m. ET

Webinar Link: https://bit.ly/3bCwvPU

Mr. Varner will be available for questions following the company presentation. The webinar will be recorded and available for replay on Genprex’s website for a period of time. A replay will also be available on CEORoadshow.com following the webinar.

The CEO Roadshow webinar series features small and mid-cap stocks that are on the verge of a breakout or have other near-term developments making them an attractive long-term investment opportunity.